The legalisation of drugs, once a revolutionary pipedream, is going mainstream. Is it too early for investors to buy in? Simon Wilson investigates.
Why legalise drugs?
Because the so-called 'war on drugs' – prohibition backed by mass criminalisation and tough policing – has failed to achieve its core objective of reducing the use of drugs. Instead, it has created huge 'collateral damage' in consumer countries – including mass incarceration and the waste of public resources, corruption, the spread of avoidable diseases, and the use of drugs in more dangerous and adulterated forms.
More broadly, in both producer and [...]
Want to read this article now?
Already a MoneyWeek subscriber? Please log in below.
Not a subscriber? Sign-up now for a 4 week FREE trial to get instant access.